Trying to get this restored on IHUB since I don't see how it could possibly be removed as being off topic (no need to guess who most likely removed it - phft). Post was a response to a question posed as to how many real longs are on the IHUB board and view the posts:
I have the naysayers on ignore. Amazing how few posts are really made by those that I believe actually have skin in the game. I differentiate between the two by those that actually provide some sort of DD or cognitive input, do not post repetitiously day after day the same dogma of data and events years old, that aren't posters with many aliases, and don't show joy when the stock goes down. That in itself shows an obvious agenda IMO.
Those that discuss the progress of the science, the trials, etc. are all still extremely positive based on the 100% successful trial results to date, the fact we are less than 200MM shares and have been able to advance three drugs to successful conclusion in P2 trials with no overhanging debt, and the obvious desire by BP to own our pipeline of products as evidenced by the numerous CDA's.
Volume is obviously being manipulated by MM's being the henchmen for those that need the price to stay low and their need for lots of shares which they have shorted, and have not been able to cover though they have been trying relentlessly for nearly a year, is going to come to bite them in the ass royally in the not too distant future.
I do hear some exasperation from true stockholders over the share price but to a man they realize it is a complete disconnect with the true value of the company. This is evidenced by Brilacidin already being a multi-billion dollar drug with its impressive results against UC, OM, ABSSSI, and Dr. B expressing such optimism for it as a major player of the future in the dermatology arena which it will target within a year or so. K is already a multi-billion dollar drug with its successful evidence of working in the p53 pathway as it showed in pre-clinical trials and met the goals of the OC trial which was set up by BP to answer their main questions as to how K worked in attacking tumors. It passed w/ flying colors.
Current speed bumps include finalizing the oral delivery method for both K and B, a gel/foam for B for use in sigmoid colitis of the anal region of the GI tract, and getting Compassionate Use OK for both B and K in addition to the obvious delay of the P top end results which are no fault of the company or mgt. These are just current delays, nothing out of the ordinary for bio yet made to look like the death of the company by those trying to scare shares out of longs hands.
There are obviously a boatload of eyes on this board by many who never speak up and share their thoughts, many who most likely have a nice position in the company, and some support from them would be most welcome but that cannot be counted on. I do believe the vast majority of them know what they own and are as confident as those few of us who post positively on a regular basis.
To those that denigrate IPIX, name one other bio start up, or even any other BP, that has the current explosive pipeline as does IPIX which addresses many, many multi-billion dollar markets and still has many more not even realized yet (as we have been told is the case w/ B, can be the case w/ P for auto-immune diseases), and most likely will occur with K as THE combo drug of choice for nearly every current cancer treatment on the market.
Easy to see why those of us w/ positive attitudes sleep well at night. We don't need to employ MM games, as those trying to keep the SP low do, to try and make our case.
Look for facts, not opinions, and put those on ignore that only deal in negative opinions not backed up with facts and the board becomes again a source of good info and not the current denigration of the company. It is like when graffiti artists paint railroad cars and downtown buildings for their "art" and then move on to leave nothing but a sore spot in the neighborhood. That is how I treat the negative posts with no factual backup
I have the naysayers on ignore. Amazing how few posts are really made by those that I believe actually have skin in the game. I differentiate between the two by those that actually provide some sort of DD or cognitive input, do not post repetitiously day after day the same dogma of data and events years old, that aren't posters with many aliases, and don't show joy when the stock goes down. That in itself shows an obvious agenda IMO.
Those that discuss the progress of the science, the trials, etc. are all still extremely positive based on the 100% successful trial results to date, the fact we are less than 200MM shares and have been able to advance three drugs to successful conclusion in P2 trials with no overhanging debt, and the obvious desire by BP to own our pipeline of products as evidenced by the numerous CDA's.
Volume is obviously being manipulated by MM's being the henchmen for those that need the price to stay low and their need for lots of shares which they have shorted, and have not been able to cover though they have been trying relentlessly for nearly a year, is going to come to bite them in the ass royally in the not too distant future.
I do hear some exasperation from true stockholders over the share price but to a man they realize it is a complete disconnect with the true value of the company. This is evidenced by Brilacidin already being a multi-billion dollar drug with its impressive results against UC, OM, ABSSSI, and Dr. B expressing such optimism for it as a major player of the future in the dermatology arena which it will target within a year or so. K is already a multi-billion dollar drug with its successful evidence of working in the p53 pathway as it showed in pre-clinical trials and met the goals of the OC trial which was set up by BP to answer their main questions as to how K worked in attacking tumors. It passed w/ flying colors.
Current speed bumps include finalizing the oral delivery method for both K and B, a gel/foam for B for use in sigmoid colitis of the anal region of the GI tract, and getting Compassionate Use OK for both B and K in addition to the obvious delay of the P top end results which are no fault of the company or mgt. These are just current delays, nothing out of the ordinary for bio yet made to look like the death of the company by those trying to scare shares out of longs hands.
There are obviously a boatload of eyes on this board by many who never speak up and share their thoughts, many who most likely have a nice position in the company, and some support from them would be most welcome but that cannot be counted on. I do believe the vast majority of them know what they own and are as confident as those few of us who post positively on a regular basis.
To those that denigrate IPIX, name one other bio start up, or even any other BP, that has the current explosive pipeline as does IPIX which addresses many, many multi-billion dollar markets and still has many more not even realized yet (as we have been told is the case w/ B, can be the case w/ P for auto-immune diseases), and most likely will occur with K as THE combo drug of choice for nearly every current cancer treatment on the market.
Easy to see why those of us w/ positive attitudes sleep well at night. We don't need to employ MM games, as those trying to keep the SP low do, to try and make our case.
Look for facts, not opinions, and put those on ignore that only deal in negative opinions not backed up with facts and the board becomes again a source of good info and not the current denigration of the company. It is like when graffiti artists paint railroad cars and downtown buildings for their "art" and then move on to leave nothing but a sore spot in the neighborhood. That is how I treat the negative posts with no factual backup
12
